In this Chemistry Today article, John McDermott and Andy Lewis examine how artificial intelligence is reshaping formulation development by moving drug product design from traditional trial-and-error approaches toward more predictive, data-driven strategies.
Combining Human Expertise and AI for Better Formulation Decisions
The article explores how AI can help scientists identify promising formulation options faster, reduce experimental burden, and improve development efficiency, while emphasizing that human expertise remains essential for interpreting data, guiding decisions, and ensuring successful outcomes.
Read the full article on Chemistry Today website here.